Illumina SEC filings document the company’s genomics technology business, financial results, governance and capital actions. Form 8-K reports cover quarterly and annual operating results, preliminary financial updates, share repurchase authorization, management and board changes, and Regulation FD disclosures.
The filing record also includes definitive proxy materials for annual meeting matters, director elections, compensation and shareholder voting. Material-event filings document completed acquisition activity, including the purchase of SomaLogic and Sengenics aptamer-based and functional proteomics assets, along with exhibits, common-stock repurchase disclosures and other capital-structure records.
Illumina, Inc. (ILMN) established an unsecured commercial paper program under which it may issue notes, with aggregate principal outstanding capped at $1.0 billion at any time. Amounts may be borrowed, repaid and re-borrowed. As of October 8, 2026, no CP Notes were outstanding, and net proceeds from issuances are expected to be used for general corporate purposes.
Maturities may not exceed 397 days from issue. Notes may be issued at a discount from par or at par with fixed or floating interest rates. Initially, three commercial paper dealers will either purchase notes from Illumina or arrange their sale to purchasers, and a national bank will serve as issuing and paying agent. The notes are unregistered and may be offered or sold in the United States only if registered or an applicable exemption applies.
Illumina, Inc. CEO Jacob Thaysen reported 1,303 shares delivered or withheld for payment of exercise price or tax liability on October 5, 2026, at a reported price of $293.69 per share. He held 107,770 shares directly after the transaction. No Rule 10b5-1 plan is reported.
For Illumina, Inc. common stock, FMR LLC and Abigail P. Johnson each report beneficial ownership of 16,169,439 shares, or 10.7% of the class. FMR LLC reports sole voting power over 15,355,487 shares; Abigail P. Johnson reports no voting power. Both report sole dispositive power over 16,169,439 shares. The disclosure says other persons may receive dividends or sale proceeds, but no other person's interest exceeds 5% of the class.
Illumina, Inc. director Keith A. Meister acquired 107 common shares on September 30, 2026, in lieu of cash for his third-quarter 2026 board and committee retainer fees. He elected to receive 100% of his 2026 board and committee cash retainer fees in stock. His direct holdings after the acquisition were 6,887 shares. A separate indirect position of 770,350 shares is held for accounts of the Corvex Funds; Corvex Management LP is their investment adviser, and its general partner is controlled by Meister.
Illumina, Inc. director Scott B. Ullem acquired 113 shares of common stock on September 30, 2026; the reported transaction price was $219.8037 per share. His directly held shares following the transaction totaled 11,143. The shares represented his third-quarter 2026 board and committee cash retainer fees. He elected to receive 100% of those fees in stock, with the share count based on the cash compensation otherwise payable divided by the quarter’s volume weighted average closing price per share.
ILLUMINA, INC. (symbol: ILMN) is the issuer of record for a Form 4 filing submitted to the SEC. Coletti Julie Ann reported acquisition or exercise transactions in this Form 4 filing.
ILLUMINA, INC. (ILMN) reported that its Chief Legal Officer, Julie Ann Coletti, received multiple equity awards on September 8, 2026. These include grants of 4,549 shares of common stock in restricted stock units vesting in four equal annual installments and 14,214 shares of common stock in restricted stock units vesting in three annual installments beginning September 5, 2027.
She also received two grants of 5,307 performance stock units each, expiring December 31, 2028, which are contingently settled in common stock based on Illumina’s three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026–2028 and on relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares ultimately issued under each performance award may range from 0% to 250% of the target amount, subject to continued service. No Rule 10b5-1 trading plan is reported.
ILLUMINA, INC. (ILMN) reported that Steven Barnard, SVP and Chief Technology Officer, had 408 shares of common stock disposed of on September 5, 2026, as shares were delivered or withheld for payment of exercise price or tax liability. Following this transaction, he holds 40,927 shares directly. No Rule 10b5-1 trading plan is reported.
ILLUMINA, INC. (ILMN) director Keith A. Meister reported indirect open-market sales totaling 263,560 shares of Illumina common stock on September 2–4, 2026, for private investment funds advised by Corvex Management LP. The sales were executed at reported weighted average prices including $213.20, $215.20, $218.39 and $221.55 per share. Corvex and Mr. Meister disclaim beneficial ownership of the funds’ holdings except to the extent of their pecuniary interest. No Rule 10b5-1 trading plan is reported, and Mr. Meister is shown with 6,780 shares held directly as of September 2, 2026.
ILLUMINA, INC. (ILMN) received a Rule 144 notice from Corvex Management, an affiliate of a company director, for a proposed sale of 150,000 shares of common stock through Goldman Sachs & Co. LLC on the Nasdaq Stock Market. The proposed sale has an aggregate market value of $31,987,500. Illumina common shares outstanding are listed as 151,000,000 as of the notice; this is a baseline figure, not the amount being sold. In the three months before the notice, Corvex reported multiple open-market sales of Illumina shares on various August and September 2026 dates.
ILLUMINA, INC. (ILMN) director Keith A. Meister reported indirect sales of 375,941 shares of Illumina common stock on August 25–27, 2026. The shares were sold by Corvex-managed investment funds at weighted average prices from about $225.26 to $231.23 per share. Meister and Corvex disclaim beneficial ownership beyond their pecuniary interests. He also reports 6,780 shares held directly.